Canine organoids for drug efficacy and safety testing: an innovative preclinical model for drug development

被引：0

作者：

Mochel, J. P. ^{[1
]}

Jergens, A. E. ^{[1
]}

Chandra, L. ^{[1
]}

Kingsbury, D. ^{[1
]}

Atherly, T. ^{[1
]}

Mochel, A. ^{[1
]}

Fernandez-Zapico, M. E. ^{[2
]}

Wang, K. ^{[2
]}

Kim, H. J. ^{[3
]}

Allenspach, K. ^{[1
]}

机构：

[1] Iowa State Univ, Coll Vet Med, Ames, IA USA

[2] Mayo Clin, Rochester, MN USA

[3] Univ Texas Austin, Austin, TX 78712 USA

来源：

JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS | 2018年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

O20.1

引用

页码：68 / 68

页数：1

共 50 条

[21] Value of new biomarkers for safety testing in drug development
Hewitt, Philip
Herget, Thomas
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2009, 9 (06) : 531 - 536
[22] Preclinical and clinical drug development
Henry, Brian
IDRUGS, 2007, 10 (02) : 106 - 108
[23] Specialized Anti-HIV Testing: Expediting Preclinical Drug Development
Robert W. Buckheit
Drug information journal : DIJ / Drug Information Association, 1997, 31 (1): : 13 - 22
[24] The Pediatric Preclinical Testing Program (PPTP): changing the paradigm for drug development
Houghton, P.
EJC SUPPLEMENTS, 2008, 6 (12): : 8 - 8
[25] Hematotoxicity testing by cell clonogenic assay in drug development and preclinical trials
Pessina, A
Malerba, F
Gribaldo, L
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (08) : 1055 - 1065
[26] Reducing attrition in drug development: smart loading preclinical safety assessment
Roberts, Ruth A.
Kavanagh, Stefan L.
Mellor, Howard R.
Pollard, Christopher E.
Robinson, Sally
Platz, Stefan J.
DRUG DISCOVERY TODAY, 2014, 19 (03) : 341 - 347
[27] Validation of a canine intestinal organoid model as a preclinical screen to assess GI toxicity in novel oncology drug development
Hoyle, Sarah M.
Tonge, Nicola
Seaman, Charlotte
Drinkwater, Mark
Bonas, Adam
Murray-Tait, Vicky
Bonavita, Aude-Marine
Booth, Cath
CANCER RESEARCH, 2018, 78 (13)
[28] Data quality in drug discovery and preclinical drug development
Steckler, T.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S152 - S153
[29] Is the guinea pig model a necessary step in preclinical TB drug testing?
Ahmad, Z.
Pinn, M.
Tyagi, S.
Peloquin, C.
Nuermberger, E. L.
Grosset, J.
Karakousis, P. C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
[30] The In Vitro Human Fracture Hematoma Model - A Tool for Preclinical Drug Testing
Pfeiffenberger, Moritz
Hoff, Paula
Thone-Reineke, Christa
Buttgereit, Frank
Lang, Annemarie
Gaber, Timo
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2020, 37 (04) : 561 - 578

← 1 2 3 4 5 →